Paravertebral Catheter Analgesia Versus Epidural Analgesia for Totally Minimally Invasive Esophagectomy
Official title: PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies: a Randomized Controlled Trial
Run by University Hospital, Lille · NCT07434739 · Data updated 2026-11-12
This trial tests whether paravertebral catheter analgesia can provide comparable pain control to epidural analgesia for patients undergoing totally minimally invasive esophagectomy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 506 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille) |
| Status | Recruiting |
| Started | June 22, 2026 |
| Main results expected | June 22, 2028 |
| Study ends | November 22, 2028 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT07434739 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with resectable esophageal cancer planned for totally minimally invasive esophagectomy (Ivor-Lewis type) with laparoscopic abdominal and thoracoscopic thoracic approaches.
✕Probably not a fit
Patients who have contraindications to regional anesthesia or those not undergoing a totally minimally invasive approach may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study compares two pain-management approaches in adults undergoing totally minimally invasive esophagectomy for esophageal cancer. Participants are assigned to receive either paravertebral catheter analgesia or thoracic epidural analgesia as part of multimodal analgesia. The trial focuses on postoperative pain, recovery markers, and safety in a real-world surgical setting. It leverages robot-assisted or non-robot-assisted minimally invasive techniques and standard adjuvant care. Results could inform pain management choices to optimize recovery after esophagectomy.
Why it matters
Potential benefit: If successful, patients may experience effective pain control with potentially fewer opioid needs and faster recovery.
How similar studies have gone: Previous analgesia studies support regional techniques for thoracic surgery, but direct comparisons in this exact minimally invasive esophagectomy context are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient requiring totally minimally invasive surgical esophagectomy (robot-assisted or not) with 2 Ivor-Lewis type approaches: laparoscopy for the abdominal approach and thoracoscopy for the thoracic approach. * Age ≥ 18 years old * Patient who has given written consent to participate in the trial * Socially insured patient * Patient willing to comply with all study procedures and duration Exclusion Criteria: * \- Intervention planned by open esophagectomy (laparotomy and/or thoracotomy) * 3-stage esophagectomy, McKeown type * Obesity with body mass index ≥ 35 kg.m-2 (due to the foreseeable difficulties arising from this BMI). * Pregnancy * Haemostasis trouble * ASA score \> 3 * Renal failure (eGFR \< 50 mL/min) * Ongoing opioid use (\>3 months prior to the day of surgery) * Contraindication to local anesthesia * Local infection * Inability to receive informed information * Person deprived of the liberty * Person benefiting from a system of legal protection (guardianship…)
Where it's running
-
CHU de Lille
Lille, France Recruiting
Study contacts
- Study coordinator: Cédric CIRENEI,, MD
- Email: cedric.cirenei@chru-lille.fr
- Phone: 03 20 44 59 62
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Survey for patients with esophageal cancer and upper digestive diseases
This study is trying to gather information from patients with esophageal cancer and other upper digestive issues to see how they are doing after treatment and improve future care.
-
Comparing outcomes of minimally invasive and open esophagectomy for esophageal cancer
This study is trying to see if patients with esophageal cancer do better in terms of recovery and quality of life after having a minimally invasive surgery compared to traditional open surgery.
-
Tramadol vs Morphine for Postoperative Pain After Laparoscopic Abdominal Surgery
This study tests whether tramadol can provide comparable pain relief to morphine after laparoscopic abdominal surgery when used as part of multimodal pain management.
-
PF-08098488 in adults with advanced solid tumors
This study tests PF-08098488 in adults whose cancer has progressed or returned after prior treatment.
-
Pain management plan implementation for major open abdominal surgeries
This trial tests an opioid-epidural pain management approach to see if it improves post-surgical pain control for adults undergoing open abdominal procedures like colectomy, hepatectomy, and nephrectomy.
-
Modular Robot-Assisted Esophagectomy vs. Conventional Minimally Invasive Esophagectomy for Esophageal Cancer
This trial tests whether modular robotic-assisted esophagectomy using the Carina platform works better than conventional 3D thoracoscopic esophagectomy for people with resectable esophageal cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.